Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on refinancing transaction relating to the INEOS group
Mandate

Vinge advises on refinancing transaction relating to the INEOS group

February 17, 2010

Vinge has advised a bank syndicate including Barclays Capital, Bank of America Merrill Lynch and ING Bank in connection with the Swedish part of the refinancing of the INEOS group (the world's third largest chemicals company) and the group company, Kerling PLC's bond issue for EUR 785 million. Kerling PLC is one of Europe's leading producers of PVC and caustic soda.
 
The INEOS group refinancing has secured assets in five jurisdictions, including Sweden.
 
Vinge's team primarily consisted of Fredrik Wilkens (responsible partner), Emma Stuart-Beck, Katarina Rodell and Karin Lidman.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026